2552 Real Life treatment sequences and survival of men with metastatic castrate-resistant prostate cancer (mCRPC) receiving cabazitaxel in UK clinical practice. (September 2015) - Pan, S.; Bahl, A.; Gee, A.; Butt, M.; Malik, Z.; Dew, R.; Birtle, A.